CGRP has a role in infection-induced pain

While the role of calcitonin gene-related peptide (CGRP) in headache and migraine is well established, Dr Isaac Chiu speaking at #AHSAM21 sought to unravel the role of CGRP in infection-induced pain. CGRP signalling to gut epithelium protects against Salmonella infection; conversely, blocking CGRP could enhance innate immunity and improve the outcome of skin infections.

CGRP activity in skin infections

Dr Isaac Chiu explained that nociceptor sensory neurons are specialized to detect microbial pathogens, protecting the body by initiating the sensation of pain and eliciting defensive behaviors. Bacterial infections produce pain by unknown molecular mechanisms, although they are presumed secondary to immune activation.1

Innate immune cells express CGRP receptors

CGRP is released from nociceptive terminals in skin and gut infections when activated by bacterial pathogens, which modulates RAMP1 on immune and epithelial cells.2 Acute targeting of CGRP may be useful in cases where CGRP inhibits innate immune activity (e.g., invasive skin infections) to benefit the outcome of infection.

Blocking CGRP could enhance innate immunity and improve the outcome of infection

Streptococcus pyogenes is a major cause of infections, including pharyngitis, impetigo, scarlet fever, boils, cellulitis, necrotising fasciitis, and the level of pain reported is often ‘out of proportion’ with early clinical manifestations. Flesh-eating bacteria hijack a pain response that suppresses host defense mechanisms.

Targeting the peripheral nervous system and blocking neuro-immune communication may be a promising strategy to treat highly invasive bacterial infections. S. pyogenes produces pain during bacterial invasion through streptolysin S, which induces TRPV1 neurons to release CGRP into infected tissues.3 Botulinum neurotoxin A and CGRP antagonists block neuron-mediated suppression of host defense, thereby preventing and treating S. pyogenes necrotizing infection in animal studies.

 

CGRP protects against gut infections

In the gut, CGRP maintains gut epithelial homeostasis and the microbiome composition. Peyer’s patch M cells are entry points for enteric pathogens, and CGRP suppression of M cells protects against Salmonella infections.2

Extrinsic nociceptor neurons mediate protection from Salmonella infection by direct sensing and release of CGRP, which leads to suppression of M cell density and maintenance of segmented filamentous bacteria colonization of the ileum.2 On the other hand, long-term blockade of CGRP may lead to defects in gut epithelial barrier function and host defense against gut pathogens.

CGRP signalling to gut epithelium protects against Salmonella infection

Based on available animal data, Dr Chiu concluded that while blocking CGRP activity may offer a therapeutic approach to skin infections, people on anti-migraine treatments that target CGRP-RAMP1 signaling should be aware of the potential for chronic effects on the immune and gastrointestinal systems, that may include an increased susceptibility to infections.

 

For the latest updates on sea.progress.im, subscribe to our Telegram Channel https://bit.ly/telePiM

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

References
  1. Chiu IM, et al. Nature 2013;501(7465):52–7.
  2. Lai NY, et al. Cell 2020;180(1):33–49.e22.
  3. Pinho-Ribeiro FA, et al. Cell 2018;173:1083–97.
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country